Keywords: moves, back, into, iud, market, buying, gynopharma
J&J Moves Back Into IUD Market, Buying GynoPharma
Article | 21 August 1995
For an undisclosed sum, Johnson & Johnson has acquired New-Jersey-based GynoPharma, which holds a 95% share of the US intrauterine device market. ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Italy's pharma market slump set to continue, warns GlobalData
